Methylation of histone 3 at lysine 9 (H3K9) is widely regarded as a major roadblock for cellular reprogramming and interference with associated methyltransferases such as EHMT1 and EHMT2 (also known as GLP and G9A, respectively) increases the efficiencies at which induced pluripotent stem cells (iPSCs) can be derived. Activation of histone and DNA demethylases by ascorbic acid (AA) has become a common approach to facilitate the extensive epigenetic remodeling required for iPSC formation, but possible functional interactions between the H3K9 methylation machinery and AA-stimulated enzymes remain insufficiently explored. Here we show that reduction of EHMT1/2 activity counteracts iPSC formation in an optimized reprogramming system in the presence of AA. Mechanistically, EHMT1/2 activity under these conditions is required for efficient downregulation of somatic genes and transition into an epithelial state. Of note, transient inhibition of EHMT1/2 during reprogramming yields iPSCs that fail to efficiently give rise to viable mice, suggesting persistent molecular defects in these cells.
SUMMARY
Methylation of histone 3 at lysine 9 (H3K9) is widely regarded as a major roadblock for cellular reprogramming and interference with associated methyltransferases such as EHMT1 and EHMT2 (also known as GLP and G9A, respectively) increases the efficiencies at which induced pluripotent stem cells (iPSCs) can be derived. Activation of histone and DNA demethylases by ascorbic acid (AA) has become a common approach to facilitate the extensive epigenetic remodeling required for iPSC formation, but possible functional interactions between the H3K9 methylation machinery and AA-stimulated enzymes remain insufficiently explored. Here we show that reduction of EHMT1/2 activity counteracts iPSC formation in an optimized reprogramming system in the presence of AA. Mechanistically, EHMT1/2 activity under these conditions is required for efficient downregulation of somatic genes and transition into an epithelial state. Of note, transient inhibition of EHMT1/2 during reprogramming yields iPSCs that fail to efficiently give rise to viable mice, suggesting persistent molecular defects in these cells.
Genetic interference with the H3K9 demethylase KDM3B ameliorated the adverse effect of EHMT1/2 inhibition on iPSC formation. Together, our observations document novel functions of H3K9 methyltransferases during iPSC formation and suggest that the balancing of AAstimulated enzymes by EHMT1/2 supports efficient and error-free iPSC reprogramming to pluripotency.
INTRODUCTION
Covalent chromatin modifications such as DNA and histone methylation modulate gene expression and stabilize epigenetic states in a wide variety of biological processes. The genomewide and locus-specific abundance of chromatin marks is determined by counteracting enzymatic activities, such as histone methyltransferases and demethylases (Black et al., 2012) .
Lysine methylation at position 9 of histone 3 (H3K9 methylation) is an epigenetic mark predominantly associated with gene repression that is conserved during evolution and plays important regulatory functions during embryonic development, sex determination, neuronal plasticity, immune cell function and tumorigenesis (Benevento et al., 2015; Casciello et al., 2015; Kuroki and Tachibana, 2018; Scheer and Zaph, 2017) . H3K9 trimethylation in heterochromatic regions is established by SETDB1 and SUV39H1/2 (Kang, 2015; Peters et al., 2001; Rice et al., 2003) , while the H3K9 mono-and dimethyltransferases EHMT1 and EHMT2 (also known as GLP and G9A, respectively) mediate gene silencing at euchromatic loci (Shinkai and Tachibana, 2011) . Enzymes involved in the establishment of H3K9 methylation are repressors of core pluripotency-associated gene loci (Epsztejn-Litman et al., 2008) and, thus, have particular relevance for physiological and experimentally-induced changes in cell identity (Becker et al., 2016; Feldman et al., 2006) . Inefficient removal of H3K9 methylation is a frequent cause of incomplete transcriptional reprogramming after somatic cell nuclear transfer (Matoba et al., 2014) and has been reported to impede the binding of reprogramming factors to the genome during the derivation of induced pluripotent stem cells (iPSCs) (Soufi et al., 2012) . Consequently, the formation of mouse (Chen et al., 2013b; Liang et al., 2012; Sridharan et al., 2013; Tran et al., 2015; Wang et al., 2011; Wei et al., 2017) and human (Onder et al., 2012; Soufi et al., 2012) iPSCs can be substantially facilitated by interferences with H3K9 methyltransferases or by activation of respective demethylases. Despite the importance of H3K9 methyltransferases for cellular reprogramming and different physiological and pathological processes (Shankar et al., 2013) , our understanding of the regulatory interactions controlling the function of these enzymes in different cellular contexts remains incomplete. We reasoned that the systematic comparison of cells that reprogram at markedly different efficiencies could be utilized to discover unexplored aspects of the H3K9 methylation machinery. By taking this approach we were able to assign specific and context-dependent functions to the histone methyltransferases EHMT1/2 during the reprogramming of fibroblasts into iPSCs by the "Yamanaka transcription factors (TFs)" OCT4, KLF4, SOX2 and MYC (OKSM). In particular, we report the unexpected finding that EHMT1/2 activity supports efficient and faithful establishment of pluripotency in conditions that favor histone demethylation.
RESULTS

Context-dependent roles of EHMT1/2 activity during mouse fibroblast reprogramming
We decided to compare the role of H3K9 methylation during iPSC formation driven solely by the OKSM factors ("basal reprogramming") to OKSM-driven reprogramming supported by chemical modulation of the TGFb and WNT signaling pathways (via iALK5 and CHIR99021, respectively) and of chromatin state (via ascorbic acid, AA) ("3c enhanced reprogramming").
These compounds are commonly used to facilitate reprogramming and pluripotent cell culture (Dakhore et al., 2018) and iPSCs generated in this manner are developmentally fully competent (Amlani et al., 2018) . 3c reprogramming yields approximately 50 times more stable iPSC colonies than basal reprogramming and does so in a shorter period of time (six rather than twelve days of OKSM expression) (Penalosa-Ruiz et al., 2019; Saunders et al., 2017; Schwarz et al., 2018; Stelzer et al., 2015; Vidal et al., 2014) . We therefore speculated that 3c might enhance iPSC formation by counteracting H3K9 methylation more efficiently than OKSM factors alone.
To our surprise, both H3K9 mono-and dimethylation (H3K9me1/2) levels increased shortly after initiation of OKSM expression (24 hours; 24h) in 3c conditions compared to uninduced mouse embryonic fibroblasts (MEFs), while a less pronounced increase was observed during basal reprogramming ( Figure 1A,B) . This coincided with increased protein levels of EHMT1 and EHMT2, the two major methyltransferases that catalyze H3K9me1/2 in mammalian cells (Figure 1C and S1A) . We also observed transcriptional upregulation of all major H3K9 methyltransferases at this time while no such trend was observed with the corresponding demethylases ( Figure S1B ). The heterochromatic H3K9me3 mark ( Figure 1A,B) as well as the activating marks H3K4me2 and H3K4me3 ( Figure S1C ) were reduced during basal and 3c reprogramming, supporting the notion that dynamic chromatin remodeling commences early during iPSC formation (Koche et al., 2011) . EHMT1 and EHMT2 are two closely structurally related enzymes that work as heterodimers in pluripotent cells (Tachibana et al., 2005) . Treatment of mouse embryonic fibroblasts (MEFs) undergoing reprogramming with standard doses (1 µM) of UNC0638, an efficient and specific substrate inhibitor of EHMT1/2 activity (Vedadi et al., 2011) , greatly reduced levels of H3K9me2 (Figure 1D) , demonstrating that the gain of this chromatin modification during early stages of iPSC formation is at least in part driven by active histone methylation. Together, these observations suggest that upregulation of components of the H3K9 methylation machinery is an early and previously unappreciated event during cellular reprogramming, which appears more pronounced in 3c enhanced compared to basal iPSC reprogramming conditions. Chemical and genetic interference with EHMT1/2 during OKSM-driven reprogramming of mouse neural progenitor cells (Shi et al., 2008) and fibroblasts (Sridharan et al., 2013) has been reported to facilitate iPSC formation, supporting the prevalent notion that H3K9 methyltransferase activity counteracts the induction of pluripotency. Accordingly, EHMT1/2 inhibition via UNC0638 substantially increased the efficiency of iPSC formation from MEFs in basal conditions in our system (Figure 2A,B; upper panels). To our surprise, the formation of stable, transgene-independent iPSC colonies was strongly impaired (3-5 fold) when UNC0638 was administered during 3c enhanced reprogramming (Figure 2A,B ; lower panels). We also observed significantly reduced colony numbers during 3c enhanced reprogramming when driving iPSC formation by OKS factors (no ectopic MYC) and when using constitutive lentiviral vectors to express OKSM (Sommer et al., 2009) (Figure S2A-C) . Together, these observations suggest that, in contrast to basal reprogramming, 3c enhanced reprogramming does not counteract EHMT1/2, but instead partially becomes dependent on the activity of these enzymes.
Molecular and cellular changes modulated by EHMT1/2 activity during iPSC formation
Next, we exposed OKSM-expressing cells at specific intervals of time to compound inhibitor.
This revealed that the reprogramming-promoting effect of EHMT1/2 inhibition on basal reprogramming as well as the reprogramming-counteracting effect of EHMT1/2 inhibition on 3c enhanced reprogramming was most pronounced when UNC0638 was administered during early reprogramming stages (days 0 to 4 during basal and days 0 to 2 during 3c enhanced reprogramming, respectively) ( Figure 2C ). To gain insight into the genome-wide transcriptional consequences of EHMT1/2 inhibition during the early stages of iPSC formation, we initially used RNA-sequencing (RNA-seq) to determine gene expression changes that distinguish basal from 3c enhanced reprogramming. K-means clustering of genes differentially expressed between starting MEFs and cells two days after initiation of OKSM expression under 3c conditions revealed four distinct groups of genes ( Figure 3A and Supplemental Table 1), two of which distinguished between basal and 3c reprogramming (Clusters 2 and 3) while two others did not (Clusters 1 and 4). Specifically, silencing of genes associated with extracellular matrix remodeling and embryonic development (Cluster 1) and activation of genes driving DNA replication and chromatin organization (Cluster 4) were similarly efficient in basal and enhanced reprogramming. In contrast, strong activation of genes associated with RNA and energy metabolism (Cluster 2) and efficient silencing of genes required for cell adhesion (Cluster 4) were only observed in presence of 3c ( Figure 3A and Supplemental Table 2 ). These observations document that basal and 3c enhanced reprogramming exhibit distinct molecular characteristics early during iPSC formation.
Next, we interrogated the consequences of EHMT1/2 inhibition on the transcriptional dynamics associated with the two different reprogramming regimens. Principal component analysis (PCA) of early reprogramming intermediates confirmed close proximity of biological replicates and suggested a more pronounced effect of UNC0638 on enhanced than on basal reprogramming ( Figure S3A ). Differential gene expression analysis confirmed this observation and identified a total of 455 genes associated with efficient reprogramming that were significantly altered in their expression levels (fold change>1.5; p<0.05) in presence of UNC0638 (Supplemental Table 3 Table 3 ), suggesting that these enzymes contribute to the silencing of somatic gene expression during iPSC formation, similar to what was recently reported for other repressive complexes . Gene ontology (GO) analysis supported this conclusion and suggested that EHMT1/2 inhibition interferes with cellular processes required for mesenchymal-to-epithelial transition ( Figure 3C and Supplemental (Li et al., 2010; Samavarchi-Tehrani et al., 2010) . Accordingly, we observed a pronounced reduction of nascent colonies with epithelial features ( 
EHMT1/2 activity balances AA-stimulated H3K9 demethylases during reprogramming
Next, we sought to investigate the molecular mechanisms responsible for the reduction of iPSC formation observed upon EHMT1/2 inhibition. Reprogramming experiments conducted in presence of single compounds revealed a significant reduction in iPSC colonies when UNC0638 was used together with AA ( Figure 4A,B) . In contrast, a slight increase in colony numbers was observed when EHMT1/2 were inhibited in presence of either CHIR99021 or iALK5 ( Figure 4B ).
This reduction in colony number observed in presence of AA alone was less dramatic than in context of 3c, raising the possibility that AA might synergize with one or both of the other two reprogramming enhancing compounds in establishing a requirement for EHMT1/2 activity.
Indeed, we observed a more pronounced reduction in iPSC colony numbers upon EHMT1/2 interference when AA was combined with iALK5 than with CHIR99021, while colony numbers remained unchanged when iALK5 was combined with CHIR99021 in absence of AA ( Figure   S4A ). EHMT1/2 inhibition has been reported to counteract cellular proliferation in cancer cells (Casciello et al., 2015) . In light of the importance of proliferative potential for iPSC formation (Li et al., 2009a; Utikal et al., 2009 ), we asked whether this could explain the observed reduction in colonies. Quantification of cells at early reprogramming stages revealed reduced cell numbers in presence of UNC0638 in all conditions, including those where EHMT1/2 inhibition favors reprogramming ( Figure S4B ). This suggests that an effect on proliferation cannot explain the reduction in iPSC reprogramming observed only in specific conditions. AA in recent years has been recognized as a potent modulator of the activity of chromatinmodifying enzymes (Cimmino et al., 2018; Monfort and Wutz, 2013) , in particular of histone and DNA demethylases. In general, activation of AA-dependent enzymes is associated with successful nuclear reprogramming and iPSC formation (Chen et al., 2013b; Esteban et al., 2010; Tran et al., 2019) . To explain our observation of impaired reprogramming in presence of AA, we speculated that EHMT1/2 might be required to balance the activities of specific enzymes that are stimulated by AA. In agreement with this notion, quantification of global H3K9me2 levels by immunofluorescence upon UNC0638 treatment revealed a slightly more pronounced reduction of this mark during enhanced than basal reprogramming ( Figure 1D) . We attempted to restore efficient reprogramming in presence of EHMT1/2 inhibitor by shRNA-mediated knockdown (KD) of the AA-stimulated H3K9 demethylases. Interference with KDM3B, which has recently been reported to be the main modulator of H3K9me2 downstream of AA in established pluripotent stem cells (Ebata et al., 2017) , strongly impaired basal reprogramming but supported 3c enhanced reprogramming in absence of UNC0638 ( Figure 4C ). Knockdown of Kdm3a had no significant effects, despite similar reduction in mRNA abundance ( Figure S4C) . Importantly, interference with KDM3B also ameliorated the reduction in iPSC colony formation during 3c enhanced reprogramming in presence of UNC0638 ( Figure 4D ). These observations further suggest context-dependent functions of the H3K9 methylation machinery during iPSC formation and support the notion that the balance between EHMT1/2 and specific AA-stimulated enzymes is required for efficient reprogramming. Of note, while we have previously shown that 3c reprogramming yields developmentally highly competent iPSCs (Amlani et al., 2018) , iPSCs derived from cells exposed to EHMT1/2 inhibition during the first 48 hours of reprogramming gave rise to significantly reduced numbers of viable pups upon blastocyst injections ( Figure   4E,F) . This raises the possibility that even transient interference with the balancing activity of these enzymes can have lasting adverse effects on the biological properties of iPSCs.
DISCUSSION
A plethora of experimental evidence has demonstrated that H3K9 methyltransferases can counteract the induction of pluripotency ex vivo. By studying the consequences of EHMT1/2 inhibition in two well-defined reprogramming conditions, our work provides several lines of insight into how interference with the H3K9 methylation machinery affects cellular and molecular changes during iPSC formation.
First, our work confirms that counteracting H3K9 methylation facilitates reactivation of the Pou5f1 locus (Chen et al., 2013b; Sridharan et al., 2013) , which is consistent with the developmental role of EHMT2 (Feldman et al., 2006) . Second, EHMT1/2 appear to be involved in the early downregulation of fibroblast-associated genes, indicating that H3K9 methyltransferases can contribute to the early silencing of the somatic program .
Why this effect is restricted to specific loci and is substantially more pronounced during enhanced reprogramming remains to be determined. It is possible that enhanced reprogramming is associated with the upregulation or stabilization of a protein co-factor that can recruit EHMT1/2 to target gene loci, as has been reported for MYC in cancer cells (Tu et al., 2018) . Third, EHMT1/2 have a highly context-dependent function during the mesenchymal-toepithelial transition necessary for reprogramming. In basal reprogramming, inhibition of EHMT1/2 facilitates upregulation of epithelial markers such as CDH1 and EpCAM, suggesting that H3K9 methylation contributes to the stable silencing of additional pluripotency-associated gene loci in somatic cells beyond Pou5f1. In striking contrast, EHMT1/2 inhibition strongly counteracts epithelization during enhanced reprogramming. This might be a consequence of the impaired silencing of fibroblast-associated gene loci discussed above or reflective of interference with other aspects of the molecular change that distinguish enhanced from basal reprogramming. It is noteworthy that EHMT1 and EHMT2 appear to have distinct roles during fibroblast reprogramming in our system. These enzymes predominantly function as a heterodimer in embryonic stem cells (Tachibana et al., 2005) , while distinct functions of these methyltransferases have been reported in other cell types (Battisti et al., 2016) .
The requirement for EHMT1/2 during enhanced reprogramming appears to be caused by AA. To our knowledge, none of the prior studies reporting facilitated reprogramming upon interference with EHMT1/2 utilized AA, explaining why this surprising interaction has been missed. In addition, most efforts to improve iPSC formation by interfering with H3K9 methylation were done at late stages during reprogramming or by using partially reprogrammed cells (Chen et al., 2013b; Sridharan et al., 2013; Tran et al., 2015) . Of note, a genetic screen for epigenetic regulators conducted during human iPSC formation (which are routinely derived and cultured in presence of AA) reported reduced reprogramming efficiencies upon knockdown of EHMT1 (Onder et al., 2012) . In order to explain the context-dependent consequences of EHMT1/2 inhibition, we propose that a balance between EHMT1/2 and AA-stimulated enzymes such as KDM3B is important for iPSC reprogramming. Of note, the impact of TET1 on the success of iPSC formation is also modulated by the presence of AA (Chen et al., 2013a) , raising the possibility that DNA demethylases might functionally interact with EHMT1/2 during enhanced reprogramming.
Our data also suggest that even transient inhibition of H3K9me2 methyltransferase activity during reprogramming results in impaired iPSC function, suggesting persistent epigenetic aberrations. The precise molecular abnormalities caused by EHMT1/2 inhibition remain to be determined, but this observation represents a cautionary note for potential undesired consequences when targeting chromatin modifiers to facilitate iPSC formation. In 
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METHODS
Mice
Derivation, handling, and genotyping of reprogrammable mice (JAX011001) with the Oct4-GFP allele were described previously (Stadtfeld et al., 2010) . All animal experiments were in accordance with the guidelines of the NYU School of Medicine Institutional Animal Care and Use Committee.
Cell culture
MEF cultures were established by trypsin digestion of midgestation (embryonic day (E) 13.5-E15.5) embryos and maintained in DMEM supplemented with 10% FBS, L-glutamine, penicillin/streptomycin, nonessential amino acids and β-mercaptoethanol. Reprogrammable MEFs were heterozygous for Rosa26-rtTA and for Oct4-GFP and either heterozygous for an inducible OKSM allele (Stadtfeld et al., 2010) or homozygous for an inducible OKS allele (Borkent et al., 2016) . Established iPSCs were cultured on irradiated feeder cells in KO-DMEM (Invitrogen) supplemented with L-glutamine, penicillin/streptomycin, nonessential amino acids, β-mercaptoethanol, 1,000 U/ml LIF and 15% FBS ("ESC medium"). Reprogramming was carried out as previously described (Vidal et al., 2014) . Briefly, 50-500 cells/cm 2 were seeded on a layer of irradiated feeder cells in ESC medium in the presence of 1 µg/ml Dox and, if applicable, Lascorbic acid (50 μg/ml), CHIR99021 (3 μM) and TGF-b RI Kinase Inhibitor II (250 nM) ("3c"). If applicable, UNC0638 (1 μM) was added. Media was changed every other day. Colonies were scored visually either after alkaline phosphatase staining or using the Oct4-GFP reporter allele.
Immunofluorescence
Cells grown on 24-well plates were fixed with paraformaldehyde (4%), permeabilized with Triton X-100 (0.5%), and stained in blocking buffer (5% goat serum, 2 mg/ml fish skin gelatin and 0.2% After counterstaining nuclei with DAPI, cells were imaged using a Neo 5.5 cSMOS camera (Andor). Imaged quantification was conducted in NIS elements. Statistical analysis was conducted in Prism (GraphPad).
Tetraploid blastocyst injections
Zygotes were isolated from BDF1 females as previously described (Stadtfeld et al., 2012) and cultured overnight until they reached the 2-cell stage. One hour after electro-fusion, 1-cell embryos were separated from embryos that had failed to fuse, cultured for another 2 days and then injected with iPSCs. Viable pups were defined as those that survived for at least three days following birth. Statistical analysis was conducted in Prism (GraphPad).
shRNA mediated knockdown 97-mer oligonucleotides against specific target genes were designed using the splashRNA algorithm (Pelossof et al., 2017) , PCR amplified using the primers miRE-Xho-fwd and miREEcoOligorev and cloned into the miRE plasmid backbones (Fellman et al. 2013) . Viruses were produced using the packaging vectors psPax2, MD2G and Pasha/DCr8. Knockdown was confirmed using quantitative PCR using gene-specific primers. All oligonucleotides are listed in Supplemental Table 5 .
Flow cytometry
Reprogramming cultures were harvested by incubation with pre-warmed 0.25% trypsin/1mM
EDTA solution for 5 minutes at 37°C. Single-cell suspensions were obtained by repetitive pipetting and transfer through a 40 µm cell strainer. Cells were incubated with eFluor 450-conjugated anti-THY1, biotin-conjugated anti-CDH1 and PE/Cy7-conjugated anti-EpCAM, followed by incubation with Streptavidin-APC (all eBiosciences) and data acquired on a FACS LSR2 (BD Biosciences), using DAPI to identify dead cells. Data analysis was conducted with FlowJo (Tree Star) and with Prism (GraphPad).
RNA library preparations and analysis.
Total RNA, extracted from cells with the RNeasy Plus Kit (Qiagen), with RIN values > 8 were subjected to Automated TruSeq stranded total RNA with RiboZero Gold library preparation (Illumina). Single-end 50 bp reads were generated with HiSeq2500. RNA-seq raw sequencing data were aligned to mouse genome version mm10 with the tophat algorithm (version 2.1.0) (Kim et al., 2013) and the use of «--b2-very-sensitive» parameter. Samtools (version 1.8) (Li et al., 2009b ) was used for data filtering and file format conversion. Aligned reads were assigned to exons with the use of the HT-seq count (version 0.5.4p3) algorithm (Anders et al., 2015) and the following parameters «-m intersection -nonempty». Differentially expressed genes were identified with the use of DESeq R package (R.3.4.4) (Anders and Huber, 2010) , excluding genes with RPKM<1. R was used for PCA analysis of all genes whose expression was above 1 RPKM in at least one condition and for k-mean clustering on Z-transformed normalized expression levels of DEGs between MEFs and early reprogramming intermediates. Gene ontology analysis was conducted using Gorilla (Eden et al., 2009 
